Home » Abstract Awards » Novartis Oncology – Best Clinical Outcomes in Breast Cancer Therapy

Novartis Oncology – Best Clinical Outcomes in Breast Cancer Therapy

Radiation Oncology Oral Presentation

 

Criteria:

Eligible candidates must be a RANZCR Radiation Oncology Member. The award will be judged on the following criteria: originality, methodology, analysis of results, clinical relevance and scientific merit.

Award:

Novartis Oncology has kindly provided ongoing medical education sponsorship to the value of $1000 (registration and travel expenses as appropriate) to attend a local medical conference. This will be awarded to the best scientific paper prepared for the Annual Scientific Meeting as judged by RANZCR.

Judging Process:

Two RANZCR representatives will be determined by the Organising Committee, after discussion with the Post Fellowship Education Committee Representative* who will then evaluate all submissions for “Best clinical outcomes in breast cancer therapy”.


* Some awards require judging to be done with the Chief Censor in Radiation Oncology.